Kenneth Edward Randall

Insider Reports History

Entity
Individual
Location
C/O Renaissance Capital Partners Ltd, 42 Shad Thames, London, United Kingdom
Signature
/s/ Thomas Nicholls
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Edward Randall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TC BioPharm (Holdings) plc 10%+ Owner Ordinary Shares [ADS] 137K $157K $1.15 Nov 30, 2022 By Renaissance Capital Partners Ltd
TC BioPharm (Holdings) plc 10%+ Owner Ordinary Shares [ADS] 2.01K $2.31K $1.15 Nov 30, 2022 Direct
TC BioPharm (Holdings) plc 10%+ Owner Warrants 106K Nov 30, 2022 By Renaissance Capital Partners Ltd
TC BioPharm (Holdings) plc 10%+ Owner Series A Warrants 70K Nov 30, 2022 By Renaissance Capital Partners Ltd
TC BioPharm (Holdings) plc 10%+ Owner Series B Warrants 70K Nov 30, 2022 By Renaissance Capital Partners Ltd

Insider Reports Filed by Kenneth Edward Randall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCBP TC BioPharm (Holdings) plc Nov 30, 2022 3 $350K 4/A Jan 11, 2023 10%+ Owner
TCBP TC BioPharm (Holdings) plc May 24, 2022 1 $23.9K 4 Jul 14, 2022 10%+ Owner
TCBP TC BioPharm (Holdings) plc Feb 10, 2022 0 $0 3 May 20, 2022 10%+ Owner